In other words, specific DNA sequence changes in the gene coding for LPHN3 were associated with and predicted whether or not a person with ADHD responded to and benefitted from treatment with stimulant medication. The gene discussed is ADGRL3; the disease is attention deficit-hyperactivity disorder.